Mitchells & Butlers plc (LON:MAB – Get Free Report) insider Phil Urban bought 55 shares of the firm’s stock in a transaction that occurred on Friday, October 10th. The stock was bought at an average cost of GBX 253 per share, for a total transaction of £139.15.
Phil Urban also recently made the following trade(s):
- On Friday, September 12th, Phil Urban purchased 52 shares of Mitchells & Butlers stock. The stock was bought at an average price of GBX 262 per share, with a total value of £136.24.
- On Friday, August 15th, Phil Urban acquired 52 shares of Mitchells & Butlers stock. The stock was bought at an average cost of GBX 264 per share, for a total transaction of £137.28.
- On Friday, July 18th, Phil Urban acquired 50 shares of Mitchells & Butlers stock. The shares were bought at an average cost of GBX 278 per share, for a total transaction of £139.
Mitchells & Butlers Trading Down 1.8%
Shares of LON:MAB opened at GBX 246 on Thursday. The stock has a 50 day moving average of GBX 258.42 and a 200 day moving average of GBX 263.81. The company has a market cap of £1.46 billion, a PE ratio of 878.57, a price-to-earnings-growth ratio of 2.76 and a beta of 1.71. Mitchells & Butlers plc has a 12-month low of GBX 194.40 and a 12-month high of GBX 308. The company has a current ratio of 0.46, a quick ratio of 0.46 and a debt-to-equity ratio of 63.56.
Analyst Ratings Changes
Read Our Latest Report on Mitchells & Butlers
About Mitchells & Butlers
Mitchells & Butlers is a leading operator of managed restaurants and pubs in the UK. It listed on the London Stock Exchange in April 2003 and is a member of the FTSE 250. Its restaurants and pubs have some of the highest average sales and profits per site in the industry and it operates the best portfolio of brands in the UK.
Featured Articles
- Five stocks we like better than Mitchells & Butlers
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to buy stock: A step-by-step guide for beginners
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Pros And Cons Of Monthly Dividend Stocks
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Mitchells & Butlers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mitchells & Butlers and related companies with MarketBeat.com's FREE daily email newsletter.